» Articles » PMID: 27698922

Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells

Overview
Journal J Cancer
Specialty Oncology
Date 2016 Oct 5
PMID 27698922
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cell signaling, growth, morphology, proliferation and tumorigenic potential are largely depending on the signaling molecules present naturally in the tumor microenvironment and the identification of key molecules that drive the tumor progression is critical for the development of new modalities for the prevention of tumor progression. High concentrations of vimentin in the blood of cancer patients have been reported, however the function of blood circulating vimentin remains unknown. Here, we investigated the functional role of exogenously supplemented vimentin on colon cancer cells and examined the Wnt Signaling activation and cancer cell invasion. Vimentin when supplemented to the cancer cells remained bound to the surface of the cancer cells. Furthermore, bound vimentin activates Wnt signaling pathway as detectable by increased β-catenin accumulation in the nucleus with concomitant activation of β-catenin-dependent transcription of Wnt signaling downstream targets. Functionally, there was an increase in the rate of cellular invasion in these cancer cells upon binding with vimentin. Our results thus suggest that free vimentin in the tumor microenvironment acts as a positive regulator of the β-catenin signaling pathway, thus providing a basis for cancer invasive properties.

Citing Articles

The Cancer Chimera: Impact of Vimentin and Cytokeratin Co-Expression in Hybrid Epithelial/Mesenchymal Cancer Cells on Tumor Plasticity and Metastasis.

Kuburich N, Kiselka J, den Hollander P, Karam A, Mani S Cancers (Basel). 2025; 16(24.

PMID: 39766058 PMC: 11674825. DOI: 10.3390/cancers16244158.


Extracellular vimentin amplifies inflammation: Perspectives for immune injury and therapeutics for periodontitis.

Yuan Z, Smith P, McCulloch C FASEB J. 2025; 39(1):e70286.

PMID: 39758044 PMC: 11701797. DOI: 10.1096/fj.202402322R.


Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.

Li H, Zhu Y, Xu L, Han T, Luan J, Li X J Exp Clin Cancer Res. 2024; 43(1):129.

PMID: 38685125 PMC: 11059585. DOI: 10.1186/s13046-024-03043-6.


Vimentin takes a hike - Emerging roles of extracellular vimentin in cancer and wound healing.

Parvanian S, Coelho-Rato L, Patteson A, Eriksson J Curr Opin Cell Biol. 2023; 85:102246.

PMID: 37783033 PMC: 11214764. DOI: 10.1016/j.ceb.2023.102246.


Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments.

Duskey J, Rinaldi A, Ottonelli I, Caraffi R, De Benedictis C, Sauer A Pharmaceutics. 2022; 14(7).

PMID: 35890345 PMC: 9325049. DOI: 10.3390/pharmaceutics14071450.


References
1.
Yang J, Zhang W, Evans P, Chen X, He X, Liu C . Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem. 2006; 281(26):17751-7. DOI: 10.1074/jbc.M600831200. View

2.
Steinmetz N, Cho C, Ablack A, Lewis J, Manchester M . Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. Nanomedicine (Lond). 2011; 6(2):351-64. PMC: 3436905. DOI: 10.2217/nnm.10.136. View

3.
Plummer E, Thomas D, Destito G, Shriver L, Manchester M . Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions. Nanomedicine (Lond). 2012; 7(6):877-88. PMC: 3567616. DOI: 10.2217/nnm.11.185. View

4.
Mitra A, Satelli A, Xia X, Cutrera J, Mishra L, Li S . Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers. Int J Cancer. 2014; 137(2):491-6. PMC: 4429009. DOI: 10.1002/ijc.29382. View

5.
Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M . Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer. 2002; 94(12):3127-34. DOI: 10.1002/cncr.10591. View